Aquapharm's R&D is focused on developing new and commercially valuable products derived from marine microbiology.
By combining a robust screening process with purification chemistry and compound elucidation, the Company is well positioned to rapidly discover new pharmaceuticals and natural products for nutrition and consumer / personal healthcare.
The core aim of the Company is the discovery of anti-infective compounds targeting bacterial infections with a focus on finding new antibiotics to treat Gram negative infections such as Pseudomonas aeruginosa and Acinetobacter spp.